Facebook icon Google+ icon Twitter icon LinkedIn icon Mail icon

BioNanoMed 2023 - Committees

Organising Committee

  • Organising Chair:
    Margit Malatschnig, Techkonnex – High-Tech Promotion, Vienna (A)
    Scientific Chairs:
    Andreas Zimmer, University of Graz (A)          
    Ruth Prassl, Medical University of Graz (A)
    Sebastian Schwaminger, Medical University of Graz (A)

Scientific Advisory Board Members

(in alphabetical order)

  • Borchard Gerrit, University of Geneva, President, Swiss Academy of Pharmaceutical Sciences (SAPhS), European Federation of Pharmaceutical Sciences (EUFEPS), (Switzerland)
  • Dailey Lea Ann, Martin Luther University Hall-Wittenberg, Biopharmacy Group, Halle (Germany)
  • Ehmoser Eva-Kathrin, University of Natural Resources and Life Sciences Vienna, Department of Nanobiotechnology  (Austria)
  • Falk Andreas, BioNanoNet Forschungsgesellschaft mbH, Graz (Austria)
  • Gabor Franz, Faculty of Life Sciences, Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna (Austria)
  • Gaspar Rogerio, University of Lisbon, Faculty of Pharmacy (Portugal)
  • Grattoni Alessandro, Houston Methodist Research Institute, Department of Nanomedicine, Departments of Surgery & Radiation Oncology, Houston (USA)
  • Groth Thomas, Martin Luther University Hall-Wittenberg, Biomedical Materials Group, Halle (Germany)
  • Gruner George, University of California Los Angeles, Nano-Biophysics Group (USA)
  • Heer Rudolf , SAL Silicon Austria Labs (Austria)
  • Haick Hossam, Technion - Israel Institute of Technology, Department of Chemical Engineering and Russell Berrie Nanotechnology Institute, Haifa (Israel)
  • Haupt Karsten , Compiègne University of Technology, CNRS Institute Enzyme and Cell Engineering, Compiègne (France)
  • Hanes Justin, The Center of Nanomedicine, Wilmer Eye Institute, John Hopkins School of  Medicine, Baltimore (USA)
  • Hinterdorfer Peter, Johannes Kepler University Linz, Institute of Biophysics, Linz (Austria)
  • Helbich Thomas, Medical University Vienna - General Hospital Vienna,  Department of Radiology, Head of Molecular and Gender Imaging, Vienna (Austria)
  • Kompella Uday B., University of Colorado Anschutz Medical Campus, Denver (USA)
  • Knoll Wolfgang, AIT Austrian Institute of Technology (Austria)
  • Langer Robert, Koch Institute for Integrative Cancer Research at MIT-Massachusetts Institute of Technology, Harvard-MIT Department Health Science and Technology (USA)
  • Meisel Hans-Jörg, BG-Kliniken Bergmannstrost, Klinik für Neurochirurgie/Neurozentrum, Halle (Germany)
  • Merkoçi Arben, Institut Català de Nanociència i Nanotecnologia (ICN2), Nanobioelectronics and Biosensors Group, Bellaterra (Spain)
  • Moghimi Moein, Centre for Pharmaceutical Nanotechnology and Nanotoxicology, Department of Pharmacy, University Copenhagen, Copenhagen (Denmark)
  • Patri Anil K., FDA -Food and Drug Administration, National Center for Toxicological Research, Washington D.C. Metro Area (USA) 
  • Pankhurst Quentin, University College London, Centre for Materials Research, Institute of Biomedical Engineering, Faculty of Engineering, London (UK)
  • Johannes Grillari, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna (Austria)
  • Singer Christian F. , Medical University Vienna, Head of Senology at Department of Obstetrics and Gynaecology, Vienna (Austria)
  • Weber Viktoria, Danube University Krems, Krems (Austria)